Jackie Partarrieu

Do you have an impactful research idea?
One that could improve care or advance science?

Apply for the ESMO Leadership & Career Development Award, offering protected research time, leadership & communication training by 3 May 26 .

🔗https://ow.ly/Gicm50YqcbZ

#Oncology #ESMOYOC

Why are older adults still not properly considered in #ClinicalResearch? In the #ESMODailyReporter, Anna Mislang & Capucine Baldini highlight key barriers and stress the need to integrate #QoL, functional independence and patient priorities in trial design.
➡️ https://ow.ly/vG6J50YmlfO

Do you: Have a strong interest in science? A passion for journalism and writing? Our paid 3-month internship might be for you! We are looking for talented candidates from all backgrounds, especially those traditionally underrepresented in publishing. Applications close 9 March 2026.

Calling all budding science writers!

Applications for our paid London-based internship, starting in June, are now open.

Deadline: 9 March 2026

Full info here: springernature.wd3.myworkdayjobs.com/en-US/Spring...

#PaidInternship #Internship #Journalism

ESMO and SIOG publish a joint paper on improving clinical trial designs for #OlderAdults with cancer. Key points: include older adults, engage patients/caregivers, use adaptive designs & integrate geriatric assessment.
Read the full paper: https://ow.ly/8QGn50Yk5jP
#GeriOnc

Want to know what’s wrong with you? “Bad Influence” argues that separating medical fact from fiction is becoming harder online

The benefits of using the internet to ask medical questions are clear. Yet Deborah Cohen, author of “Bad Influence”, is not convinced technological progress is making people healthier

The Economist is hiring Audience fellows for 2026 We are offering paid internships in our London newsroom lasting up to 12 months, to work on our social-media platforms and newsletters

The Economist is hiring Audience fellows in London to write social-media posts, produce newsletters and work on other digital projects. Apply by February 28th

📣 #ESMO26: Where the world of oncology meets and the future of cancer care takes shape. Abstract submission system now open!
⏰Deadline 12 May 2026

👉 Share your groundbreaking research
- Gain global recognition
- Present LIVE in Madrid
#esmomeetings

🔗 https://ow.ly/utHu50Y9bHC

On #WorldCancerDay, ESMO joins the global call to place people at the centre of #CancerCare, promoting patient-centred oncology adjusted to the individual characteristics of each person - a vision at the core of the ESMO Roadmap 2030. #UnitedByUnique
📌 https://ow.ly/YBUW50Y8E3k

📣 #PatientAdvocate Workshops at #ESMORareCancers26
13–14 Mar
✅ #HTA & patient input
✅ Rare cancer research
✅ Care via reference centres, guidelines & outcomes
✔️ Registration required | ESMO Advocates: reduced fee, late 11 Feb
❌ No travel grants

🔗 https://ow.ly/afrN50Y494L

📣ESMO #ClinicalPracticeGuideline Express Update on #EpithelialOvarianCancer:
- Rucaparib: 1st-line PARPi maintenance option
- MIRV: for recurrent FRα-high #OvarianCancer after 1-3 prior therapies & PFI <6 months

🔗 https://ow.ly/J06u50Y4HT8

#GYNOnc #Oncology #ESMOGuidelines

📣 ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: 💡CHALLENGE trial suggests survival benefits from structured exercise
👥Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines

🔗 https://ow.ly/lJY850Y49fR

AI in cancer care: Trust, but verify, experts caution The promise of artificial intelligence is huge, with the potential to transform and streamline cancer care, but the European Society for Medical Oncology argues that a little more evidence is required

AI is already reading scans and slides in cancer care—but is it ready to guide treatment?
ESMO says enthusiasm is racing ahead of evidence, and calls for stricter standards.
Our latest deep dive: medicalnewsinsider.substack.com/p/ai-in-canc...
#Oncology #AIethics

Are you a #YoungOncologist looking for a mentor?
The 12-month journey of the #ESMOMentorship Programme is designed for #YoungOncologists to gain 1:1 guidance from an experienced professional. #ESMOYOC #ESMOW4O
📅 Apply by: 15 Feb 2026
🔗 https://ow.ly/1sPs50Y11a7

Can less mean more? Immunotherapy changed #CancerCare — but access remains unequal. Dose optimisation may help make treatment sustainable and equitable. Equity starts with evidence. #ESMODailyReporter 📌 https://ow.ly/fT1450XZX20

#GenderMedicine ≠ women’s health. Misconceptions persist due to sex & gender data gaps in #ClinicalTrials and poor reporting. Integrating these factors is vital for fair, evidence-based care.
More in the #ESMODailyReporter 📌 https://ow.ly/Ha6P50XX5B0

Just one month to go! 🧡
On 4 February 2026, the world unites against cancer. Be part of the movement. 🌍

Find out more about getting involved for World Cancer Day at worldcancerday.org.

#WorldCancerDay 4 February 2026 #UnitedByUnique

@myesmo.bsky.social

📢 Applications open for the #MCCRworkshop!
A week-long workshop to master #ClinicalTrialDesign & learn from global experts.
🔗 Apply now: https://ow.ly/gV7t50XHtgU
📅 13–18 June 2026
✅ Apply by 30 January #ClinicalTrial #ClinicalResearch

In the #ESMODailyReporter, Eileen Yi Ling Poon discusses addressing the medical and psychosocial needs of adolescents and young adults (#AYA) w/ cancer, providing individualised treatment, targeted emotional support and age-appropriate information: https://ow.ly/O94S50XCBee

#ESMOAsia25

#ESMOAI25

Novel approaches are needed to address the general wellbeing of patients with cancer. Studies presented at #ESMO25 add to growing evidence supporting the use of #DigitalTools.
Find out more in the #ESMODailyReporter 👉 https://ow.ly/uSpY50XjC7Q

#CancerCare #DigitalHealth

#ESMO25: Are personalised #CancerVaccines the next frontier or an elusive goal? Catherine Wu discusses the exciting potential of genomics-guided personalised vaccines and some of the related challenges.
#ESMODailyReporter 👉 https://ow.ly/aMxi50Xgn37

#ImmunoOncology

Face au potentiel de l'IA en clinique et pour la recherche, les oncologues se dotent de nouvelles recommandations L’essor accéléré et fragmenté de l’intelligence artificielle en oncologie souligne la nécessité d’une gouvernance adaptée et cohérente.

Face au potentiel de l'IA en clinique et pour la recherche, les oncologues se dotent de nouvelles recommandations #ESMO25
ms.spr.ly/63329sCg2z

Concomitant publications at #ESMO25: highlighting the strength of collaboration, bringing together researchers, clinicians and journals to ensure new data is immediately accessible to the global #OncologyCommunity.

Cancer : l’IA révolutionne la recherche mais pose question pour le traitement des patients Les médecins explorent le potentiel de l’intelligence artificielle pour simplifier les essais cliniques et améliorer les traitements, tout e

📰 #Cancer : l’IA révolutionne la #recherche mais pose question pour le traitement des patients.

Le Pr Fabrice André rappelle que l'impact clinique de l'IA en oncologie reste à démontrer avant une adoption massive. ⬇

#ESMO #ESMO25

🎥 50 years of key moments.

ESMO’s 50th anniversary marks decades of achievements in #ScienceDissemination, #education and #collaboration. Take a selfie and share one of your milestones with #myESMOStory. #ESMO25

🔗 www.youtube.com/watch?v=dJTH...

🔹 @drchoueiri.bsky.social and Pr. @fandremd.bsky.social chair Sunday's presidential session at @myesmo.bsky.social, in front of a packed audience of 9,000 people.

#ESMO #ESMO25

Powerful message from Dr Anne-Marie Baird (TCD, ILCC) at #ESMO25 on gender bias in cancer care:

🔍 Recognise – bias distorts outcomes
🔧 Redesign – integrate sex & gender in every step
📊 Report – transparency in data, trials & diagnostics

#CancerEquity #PatientAdvocacy #LungCancer

Hi. The official hashtag is #ESMO25

🌍 Diversity & equity in cancer care
At #ESMO25:
📌 Inclusive research & care
📌 Youth cancer care
📌 Gender bias in diagnostics
📌 DEI in clinical trials
📅 19 Oct | 16:30–18:00 | Hall 6.1

🔗 buff.ly/zjemaK2